Published in J Vasc Interv Radiol on January 01, 2010
Spontaneous Retroperitoneal Hemorrhage (Wunderlich Syndrome) due to Large Upper Pole Renal Angiomyolipoma: Does Robotic-Assisted Laparoscopic Partial Nephrectomy Have a Role in Primary Treatment? Case Rep Urol (2013) 0.93
Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction. Quant Imaging Med Surg (2017) 0.78
The Role of Partial Nephrectomy without Arterial Embolization in Giant Renal Angiomyolipoma. Case Rep Med (2012) 0.77
Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review. Ther Adv Urol (2016) 0.75
Partial Nephrectomy for a Massive Sporadic Renal Angiomyolipoma: Case Report and Review of the Literature. Case Rep Urol (2016) 0.75
Embolization of spontaneous intratumoral hemorrhage with the hemodynamic characteristics of arteriovenous fistula in renal angiomyolipoma. Case Rep Nephrol Dial (2015) 0.75
Transarterial embolization for renal angiomyolipomas: A single centre experience in 79 patients. J Int Med Res (2017) 0.75
Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol (2012) 3.71
An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol (2003) 3.21
Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev (2004) 3.08
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int (2009) 2.63
Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology (2006) 2.59
Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol (2008) 2.57
Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol (2005) 2.56
The tuberous sclerosis complex. Ann N Y Acad Sci (2010) 2.51
Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol (2006) 2.22
Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology (2007) 2.09
Incidence and management of percutaneous transluminal angioplasty-induced venous rupture in the "fistula first" era. J Vasc Interv Radiol (2009) 2.07
Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: comparison of transarterial and translumbar techniques. J Vasc Surg (2002) 2.05
Outcomes of thrombectomy procedures performed in hemodialysis grafts with early failure. J Vasc Interv Radiol (2011) 2.02
The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int (2009) 2.00
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol (2006) 1.94
Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol (2011) 1.89
Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol (2002) 1.88
mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol (2004) 1.85
Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol (2013) 1.83
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol (2003) 1.72
Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Urology (2011) 1.70
Triple-lumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation. Radiology (2010) 1.66
Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer. J Urol (2006) 1.64
Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg (2009) 1.63
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Removal of fractured inferior vena cava filters: feasibility and outcomes. J Vasc Interv Radiol (2011) 1.59
Single-center experience with the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas. J Vasc Interv Radiol (2005) 1.59
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol (2005) 1.58
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology (2004) 1.57
Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn (2012) 1.56
Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol (2004) 1.55
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54
Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol (2011) 1.54
The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int (2013) 1.52
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes. Epilepsia (2005) 1.48
Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway. Mol Cell Neurosci (2002) 1.47
Identification of clinically significant prostate cancer by prostate-specific antigen screening. Arch Intern Med (2004) 1.46
Suspected acute pulmonary embolism: evaluation with multi-detector row CT versus digital subtraction pulmonary arteriography. Radiology (2004) 1.44
Outcomes following fibroid expulsion after uterine artery embolization. J Vasc Interv Radiol (2011) 1.43
Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol (2002) 1.43
Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int (2008) 1.41
Medical emergencies and cardiopulmonary arrests in interventional radiology. J Vasc Interv Radiol (2013) 1.41
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int (2009) 1.40
Re: A randomized, prospective comparison of the Tesio, Ash Split, and Opti-flow hemodialysis catheters. J Vasc Interv Radiol (2002) 1.39
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol (2005) 1.39
Association between utility and treatment among patients with prostate cancer. Qual Life Res (2010) 1.39
Experience with the recovery filter as a retrievable inferior vena cava filter. J Vasc Interv Radiol (2005) 1.30
Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons. Epilepsy Res (2007) 1.29
Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol (2003) 1.27
Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival? Diabetes (2003) 1.27
Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis (2003) 1.26
STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest (2010) 1.23
Inflammation in epilepsy: clinical observations. Epilepsia (2011) 1.23
Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5. Brain (2007) 1.23
Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. J Vasc Interv Radiol (2003) 1.23
CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res (2004) 1.21
Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein. Am J Physiol Renal Physiol (2010) 1.21
Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol (2009) 1.19
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer (2010) 1.18
Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol (2003) 1.17
Percutaneous transhepatic venous access for hemodialysis. J Vasc Interv Radiol (2003) 1.16
Use of the Amplatzer Vascular Plug for embolization of a large retroperitoneal shunt during transjugular intrahepatic portosystemic shunt creation for gastric variceal bleeding. J Vasc Interv Radiol (2006) 1.16
Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology. Glia (2004) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 1.16
Delayed migration of a catheter fragment from the left to the right pulmonary artery. J Vasc Interv Radiol (2004) 1.14
Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17. Am J Physiol Renal Physiol (2005) 1.12
Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol (2005) 1.12
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol (2012) 1.12
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol (2009) 1.12
Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sci Transl Med (2013) 1.11
Prevalence and treatment of cephalic arch stenosis in dysfunctional autogenous hemodialysis fistulas. J Vasc Interv Radiol (2003) 1.10
Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol (2007) 1.09
Benign prostatic hyperplasia in primary care: what you need to know. J Urol (2006) 1.08
Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain (2007) 1.07
Digital subtraction pulmonary arteriography versus multidetector CT in the detection of pulmonary arteriovenous malformations. J Vasc Interv Radiol (2008) 1.07
Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol (2003) 1.07
Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Exp Neurol (2010) 1.07
Complicated inferior vena cava filter retrievals: associated factors identified at preretrieval CT. Radiology (2012) 1.06